Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Johnson & Johnson (JNJ), Nvidia Unite to Boost AI for Surgery
11:56am, Tuesday, 19'th Mar 2024
Johnson & Johnson (JNJ) collaborates with Nvidia to facilitate the creation of AI-based models and the deployment of applications, offering a route to scale within its digital ecosystem for surgery.
Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs Of $185?
09:00am, Tuesday, 19'th Mar 2024
Johnson & Johnson (NYSE: JNJ) currently trades around $160 per share, 15% below its peak level of over $185 seen in April 2022, and it seems like it can see higher levels over time. JNJ stock was trad
Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts
06:51pm, Monday, 18'th Mar 2024
Johnson & Johnson (JNJ) closed the most recent trading day at $156.76, moving -0.9% from the previous trading session.
Nvidia and Johnson & Johnson to develop new AI applications for surgery
06:00pm, Monday, 18'th Mar 2024
Johnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:05am, Monday, 18'th Mar 2024
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
07:56am, Monday, 18'th Mar 2024
J&J (JNJ) is looking for expansion of Carvykti's label for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma.
Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own
03:00pm, Saturday, 16'th Mar 2024
Investing in your golden years is very different from investing in your young age. You cannot take as much risk now, but you still want to see your money grow.
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
03:55am, Saturday, 16'th Mar 2024
Johnson & Johnson is one of the top healthcare companies in the world, with a market cap of nearly $400 billion. The company, however, faces an uncertain future because of its unsettled talc lawsuits.
The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough
12:56pm, Friday, 15'th Mar 2024
Tax season is often stressful. However, you can soften the tax blow by using this time to do some spring cleaning by selecting stocks that will benefit you during tax season.
US FDA panel unanimously backs expanded use of J&J's CAR-T therapy
12:56pm, Friday, 15'th Mar 2024
Advisers to the U.S. Food and Drug Administration on Friday unanimously voted in favor of allowing the use of Johnson & Johnson's cell therapy as an earlier treatment for a type of blood cancer.
The 3 Most Undervalued Healthcare Stocks to Buy in March 2024
08:02am, Thursday, 14'th Mar 2024
Undervalued healthcare stocks are primed for a comeback this year, proving themselves as lucrative investments amidst a revitalized market. With a significant uptick in performance, the S&P 500 Health
US FDA staff flag safety concerns from J&J, Bristol's CAR-T therapies
08:54am, Wednesday, 13'th Mar 2024
The U.S. Food and Drug Administration's staff reviewers on Wednesday raised safety concerns over the use of Johnson & Johnson's and Bristol-Myers Squibb's cancer therapies as earlier treatments for bl
3 No-Brainer Stocks to Buy With $300 Right Now
05:21am, Wednesday, 13'th Mar 2024
Although the Dow, S&P 500, and Nasdaq have hit new highs in 2024, amazing deals can still be uncovered. Most online brokers have removed barriers to investment that had previously kept retail investor
3 Must-Have Dividend Kings for a Steady Income Stream
08:09am, Tuesday, 12'th Mar 2024
In investing, where uncertainty often reigns high, dividend kings are the beacons of income stability and growth. Among them, three companies hold enduring leads.
2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever
06:53am, Tuesday, 12'th Mar 2024
Stocks don't enter the Dow Jones Industrial Average index unless their underlying businesses are reliably profitable. Johnson & Johnson has raised its dividend payout 61 years in a row.
